Regenxbio Inc
NASDAQ:RGNX
Market Cap (Intraday) | 1.49B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | N/A |
50-Day MA | N/A |
200-Day MA | N/A |
REGENXBIO, Inc. Stock, NASDAQ:RGNX
9600 Blackwell Road, Suite 210, Rockville, Maryland 20850
United States of America
Phone: +1.240.552.8181
Number of Employees: 257
Description
REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.